We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ConocoPhillips
COP
$139B
| $1.62B | 0.63% |
13,760,455
-15,978
| -0.1% | -$1.94M |
|
27
Elevance Health
ELV
$84.2B
| $1.61B | 0.62% |
3,142,281
-203,783
| -6% | -$103M |
|
28
Linde
LIN
$227B
| $1.6B | 0.62% |
4,890,970
+617,725
| +14% | +$194M |
|
29
Union Pacific
UNP
$174B
| $1.59B | 0.62% |
7,677,335
+161,950
| +2% | +$33.2M |
|
|
30
Prologis
PLD
$132B
| $1.54B | 0.6% |
13,695,159
+3,172,948
| +30% | +$352M |
|
|
SCHW
31
Charles Schwab
SCHW
$186B
| $1.45B | 0.56% |
17,474,406
+398,159
| +2% | +$30.9M |
|
32
Accenture
ACN
$106B
| $1.45B | 0.56% |
5,441,868
-156,757
| -3% | -$43.4M |
|
33
NextEra Energy
NEE
$175B
| $1.39B | 0.54% |
16,683,152
+444,368
| +3% | +$35.9M |
|
34
RTX Corp
RTX
$299B
| $1.38B | 0.54% |
13,716,072
-1,026,448
| -7% | -$96.5M |
|
35
Meta Platforms (Facebook)
META
$1.5T
| $1.38B | 0.54% |
11,471,623
-109,949
| -0.9% | -$12.9M |
|
36
Oracle
ORCL
$417B
| $1.34B | 0.52% |
16,363,504
+1,350,286
| +9% | +$103M |
|
37
EOG Resources
EOG
$70.2B
| $1.32B | 0.51% |
10,168,870
+1,564,578
| +18% | +$208M |
|
38
McDonald's
MCD
$196B
| $1.3B | 0.5% |
4,925,088
-251,223
| -5% | -$66.3M |
|
39
Booking.com
BKNG
$159B
| $1.29B | 0.5% |
16,055,150
-17,000
| -0.1% | -$1.29M |
|
40
Walmart Inc
WMT
$884B
| $1.28B | 0.5% |
27,070,743
-1,881,177
| -6% | -$89.3M |
|
41
Honeywell
HON
$76.4B
| $1.27B | 0.49% |
6,312,021
+441,601
| +8% | +$84.4M |
|
42
Abbott
ABT
$186B
| $1.27B | 0.49% |
11,575,260
+614,693
| +6% | +$63.6M |
|
43
Bristol-Myers Squibb
BMY
$132B
| $1.27B | 0.49% |
17,591,543
+968,998
| +6% | +$73.1M |
|
44
Deere & Co
DE
$167B
| $1.23B | 0.48% |
2,877,998
-98,537
| -3% | -$40.1M |
|
45
Coca-Cola
KO
$373B
| $1.23B | 0.48% |
19,358,058
-895,108
| -4% | -$54M |
|
46
Wells Fargo
WFC
$261B
| $1.23B | 0.48% |
29,756,775
+286,460
| +1% | +$12.7M |
|
47
Bank of America
BAC
$438B
| $1.19B | 0.46% |
35,883,805
-2,732,533
| -7% | -$94.1M |
|
48
Cisco
CSCO
$482B
| $1.18B | 0.46% |
24,865,618
-1,162,568
| -4% | -$52.9M |
|
49
Lowe's Companies
LOW
$124B
| $1.13B | 0.44% |
5,663,527
+86,363
| +2% | +$17.3M |
|
50
Chubb
CB
$135B
| $1.11B | 0.43% |
5,011,697
+340,552
| +7% | +$70.9M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.